# mitox-protocol

Power calculations and sample size estimates associated with the clinical trial protocol, "A Pilot Study of the Effect of the Microbiome on Immune Checkpoint Inhibitor Response in Melanoma (OSU-19125)". 

[![DOI](https://zenodo.org/badge/190498356.svg)](https://zenodo.org/badge/latestdoi/190498356)

The goal of the study is to predict which melanoma patients will respond to immunotherapy or experience immune-related adverse events using microbiome samples and other biomarkers. 

This work is supported by Pelotonia
![mitox arrow](mitox-pelotonia-1.png)
